Clinical Trial

Omega-3, Inflammation in ADHD With AI

Name: Omega-3, Inflammation in ADHD With AI — clinical trial record (NCT07348562)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: OmInADHDAI

Completed

View on ClinicalTrials.gov →

Summary

This is a 12 week study to investigate the effects of omega-3 polyunsaturated fatty acids (PUFAs) in children with attention deficit hyperactivity disorder (ADHD).

Trial Details

NCT Number	NCT07348562
Lead Sponsor	China Medical University Hospital
Conditions	Adhd
Enrollment	15 participants
Start Date	2021-02-01
Primary Completion	2021-09-04 (estimated)
Study Completion	2021-11-20 (estimated)
Updated on ClinicalTrials.gov	2026-01-16